Terms: = Colorectal cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Diagnosis
140 results:
1. TBC1D10B promotes tumor progression in colon cancer via PAK4‑mediated promotion of the pi3k/AKT/mTOR pathway.
Chi XJ; Song YB; Zhang H; Wei LQ; Gao Y; Miao XJ; Yang ST; Lin CY; Lan D; Zhang X
Apoptosis; 2024 Aug; 29(7-8):1185-1197. PubMed ID: 38824479
[TBL] [Abstract] [Full Text] [Related]
2. eIf3a mediates malignant biological behaviors in colorectal cancer through the pi3k/AKT signaling pathway.
Huo C; Wu D; Li X; Zhang Y; Hu B; Zhang T; Ren J; Wang T; Liu Y
Cancer Biol Ther; 2024 Dec; 25(1):2355703. PubMed ID: 38782896
[TBL] [Abstract] [Full Text] [Related]
3. Exploring the Key Signaling Pathways and ncRNAs in colorectal cancer.
Lee YJ; Kim WR; Park EG; Lee DH; Kim JM; Shin HJ; Jeong HS; Roh HY; Kim HS
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674135
[TBL] [Abstract] [Full Text] [Related]
4. Broccoli extracellular vesicles enhance the therapeutic effects and restore the chemosensitivity of 5-fluorouracil on colon cancer.
Cao Y; Hou L; Li M; Zhang J; Wang L; Liu C; Luo T; Yan L; Zheng L
Food Chem Toxicol; 2024 Apr; 186():114563. PubMed ID: 38442787
[TBL] [Abstract] [Full Text] [Related]
5. Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study.
Ottaiano A; De Luca A; Santorsola M; Scognamiglio G; Di Mauro A; Chiodini P; Lambiase M; Sacco A; Petrillo A; Granata V; Fusco R; Mercadante E; Martucci N; De Luca G; Rocca A; Celentano E; Crispo A; Di Gennaro P; Tatangelo F; Ferrara G; Izzo F; Belli A; Patrone R; Delrio P; Rega D; De Franciscis S; Muto P; Ravo V; Di Franco R; Borzillo V; Santagata S; Rea G; Castaldo D; Pace U; De Feo G; Scala S; Nasti G; Normanno N
BMC Cancer; 2023 Oct; 23(1):1010. PubMed ID: 37858132
[TBL] [Abstract] [Full Text] [Related]
6. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256
[No Abstract] [Full Text] [Related]
7. colorectal cancer: Genetic alterations, novel biomarkers, current therapeutic strategies and clinical trials.
Housini M; Dariya B; Ahmed N; Stevens A; Fiadjoe H; Nagaraju GP; Basha R
Gene; 2024 Jan; 892():147857. PubMed ID: 37783294
[TBL] [Abstract] [Full Text] [Related]
8. CHSY1 promotes CD8
Sun G; Zhao S; Fan Z; Wang Y; Liu H; Cao H; Sun G; Huang T; Cai H; Pan H; Rong D; Gao Y; Tang W
J Exp Clin Cancer Res; 2023 Sep; 42(1):248. PubMed ID: 37749638
[TBL] [Abstract] [Full Text] [Related]
9. Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review.
Lawler T; Parlato L; Warren Andersen S
Cancer Causes Control; 2024 Feb; 35(2):223-239. PubMed ID: 37688643
[TBL] [Abstract] [Full Text] [Related]
10. Genomic profiling of NGS-based ctDNA from Chinese non-small cell lung cancer patients.
Xi Y; Bai Z; Gao S; Guo J; Zhang Z; Zhang H; Qu L; Xu B; Wang W; Shan G; Cui W; Bai W; Ji X
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8573-8580. PubMed ID: 37186065
[TBL] [Abstract] [Full Text] [Related]
11. Analysis of Circulating Tumor DNA in Synchronous Metastatic colorectal cancer at diagnosis Predicts Overall Patient Survival.
Sayagués JM; Montero JC; Jiménez-Pérez A; Del Carmen S; Rodríguez M; Vidal Tocino R; Montero E; Sanz J; Abad M
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176143
[TBL] [Abstract] [Full Text] [Related]
12. Novel Method for Detection of pik3ca Mutations in Circulating Tumor DNA of Patients with colorectal cancer.
Pu W; Wang F; Li K; Xing C; Zhuang Z; Wang H; Bian H; Zhang R; Xiao L
Appl Biochem Biotechnol; 2023 Dec; 195(12):7821-7831. PubMed ID: 37093531
[TBL] [Abstract] [Full Text] [Related]
13. Pilot study of gene mutations associated with Lynch syndrome in Slovak patients with breast cancer.
Krasničanová L; Saade R; Priščáková P; Gbelcová H; Kaľavská K; Karaba M; Benca J; Mego M; Repiská V
Klin Onkol; 2023; 36(2):130-134. PubMed ID: 37072247
[TBL] [Abstract] [Full Text] [Related]
14. KRAS Pathways: A Potential Gateway for cancer Therapeutics and Diagnostics.
Tripathi PK; Mittal KR; Jain N; Sharma N; Jain CK
Recent Pat Anticancer Drug Discov; 2024; 19(3):268-279. PubMed ID: 37038676
[TBL] [Abstract] [Full Text] [Related]
15. The role of microRNA-21 (miR-21) in pathogenesis, diagnosis, and prognosis of gastrointestinal cancers: A review.
Farasati Far B; Vakili K; Fathi M; Yaghoobpoor S; Bhia M; Naimi-Jamal MR
Life Sci; 2023 Mar; 316():121340. PubMed ID: 36586571
[TBL] [Abstract] [Full Text] [Related]
16. Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma.
Azzi G; Tavallai M; Aushev VN; Koyen Malashevich A; Botta GP; Tejani MA; Hanna D; Krinshpun S; Malhotra M; Jurdi A; Aleshin A; Kasi PM
Oncologist; 2023 Mar; 28(3):220-229. PubMed ID: 36562592
[TBL] [Abstract] [Full Text] [Related]
17. The roles and mechanisms of circular RNAs related to mTOR in cancers.
Cao C; Wang Y; Wu X; Li Z; Guo J; Sun W
J Clin Lab Anal; 2022 Dec; 36(12):e24783. PubMed ID: 36426933
[TBL] [Abstract] [Full Text] [Related]
18. KRAS, NRAS, BRAF, pik3ca, and AKT1 signatures in colorectal cancer patients in south-eastern Romania.
Brinzan CS; Aschie M; Cozaru GC; Deacu M; Dumitru E; Burlacu I; Mitroi A
Medicine (Baltimore); 2022 Oct; 101(40):e30979. PubMed ID: 36221415
[TBL] [Abstract] [Full Text] [Related]
19. Constructed the ceRNA network and predicted a FEZF1-AS1/miR-92b-3p/ZIC5 axis in colon cancer.
Yang X; Wu P; Wang Z; Su X; Wu Z; Ma X; Wu F; Zhang D
Mol Cell Biochem; 2023 May; 478(5):1083-1097. PubMed ID: 36219353
[TBL] [Abstract] [Full Text] [Related]
20. Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis.
He SY; Li YC; Wang Y; Peng HL; Zhou CL; Zhang CM; Chen SL; Yin JF; Lin M
World J Gastroenterol; 2022 Jul; 28(25):2920-2936. PubMed ID: 35978873
[TBL] [Abstract] [Full Text] [Related]
[Next]
